Theranos Inc., the once high-flying company whose principals face federal fraud charges over its blood-testing technology, reportedly will shut down after paying unsecured creditors with its remaining cash. The company — led by Stanford University dropout Elizabeth Holmes to a $9 billion valuation that dissipated when its finger-prick blood-testing technology couldn’t hold up to scrutiny — leaves behind yet-unresolved criminal and civil charges, a lesson in caution for investors and the media,…
Visit link:
Theranos’ bloody tale nears end with decision to shut down
